VEGFA and neoplasm: It has been done using monoclonal antibodies to make peptides that target tumor-promoting factors such as matrix metalloproteinases (MMPs), vascular endothelial growth factors (VEGF), angiotensin, and platelet-derived growth factor receptor (PDGFR) [70].